Investment professional with an advanced degree leveraging my education and hands-on experience to generate alpha in the public biotechnology sector.
Scientific and financial diligence of SMID biotechnology companies
Deep understanding of therapeutic drug development (process and landscape)
Financial modeling: drug and disease landscapes, asset NPVs, company DCF and valuation metrics, stock/index performance
Generating alpha and impact via stock ideating and pitching
Supporting specialist and generalist PMs and funds
Communicating (written and oral) relevant technical information for a lay audience
Experience with key tools of the trade (FactSet, Excel, VA, attending medical and investor conferences)
CFA Level III (exam taken Feb 2024)